| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 12 May 2025 | 6 May 2025 |
| Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 inter alia to consider and approve The Audited Standalone and Consolidated Financial statements and Financial results of the Company for the quarter and year ended March 31 2025 and 2. Any other business with the permission of Chair. Audited Standalone and Consolidated Financial Results along with Audit Report of the Company for the Quarter and Financial Year ended 31st March, 2025. The Board of Directors of the Company at its meeting held today i.e. Monday, 12th May, 2025 at Registered Office of the Company has inter alia considered and approved the following businesses: 1.Audited Standalone and Consolidated Financial Results along with Audit Report of the Company for the Quarter and Financial Year ended 31stMarch, 2025 . 2. Appointment of M/s. Rahul Doshi & Co., Chartered Accountants (FRN: 150982W, Membership No. 117160) as Internal Auditor of the Company for the Financial year 2025-26. 3. Appointment of Mr. Chintan K. Patel, Practicing Company Secretary (Membership No. A31987, COP: 11959) as Secretarial Auditor of the Company for the Financial year 2024-25.4. Appointment of Mr. Hitesh Pradeep Rijwani (DIN: 11030634) as an Additional Director (Non- Executive, Independent Director) and 5. Reconstitution of Committees of the Board w.e.f. 12thMay, 2025. (As Per BSE Announcement Dated on: 12/05/2025) Revised Outcome of the Board Meeting pertaining to clarification on Typographical Error in the Notes related to Financial Results submission for the quarter and year ended March 31, 2025 (As Per BSE Announcement Dated on 13.05.2025) | ||
| Board Meeting | 20 Mar 2025 | 20 Mar 2025 |
| Appointment of Ms. Siddhi Shah as Company Secretary w.e.f. 20.03.2025 | ||
| Board Meeting | 31 Jan 2025 | 24 Jan 2025 |
| Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 inter alia to consider and approve 1. Unaudited Standalone and Consolidated Results along with Limited Review Report for the Quarter and Nine Months ended 31st December 2024; 2. Any other business with the permission of Chairman. Outcome of the Board Meeting held on 31st January, 2025 at 04:00 P.M. inter alia considered and approved Un-audited Financial Results for the Quarter and Nine Months Ended 31st December, 2024. (As Per BSE Announcement Dated on: 31/01/2025) | ||
| Board Meeting | 17 Oct 2024 | 10 Oct 2024 |
| Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2024 inter alia to consider and approve Notice is hereby given that meeting of Board of Directors scheduled to be held on Thursday 17th October 2024 at 5:00 PM at Registered Office of the Company. Pursuant to provisions of Regulation 33 of SEBI (LODR) Regulations, 2015, Board of DIrectors has approved Unaudited Financial Results for the Quarter and Half Year Ended 30th September, 2024. (As Per BSE Announcement dated on 17.10.2024) | ||
| Board Meeting | 8 Aug 2024 | 2 Aug 2024 |
| Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2024 inter alia to consider and approve UNAUDITED RESULTS FOR QUARTER ENDED 30TH JUNE 2024 unaudited results for the Quarter ended 30th June, 2024 along with Limited Review Report. (As Per BSE Announcement dated on 08.08.2024) | ||
| Board Meeting | 5 Jul 2024 | 29 Jun 2024 |
| Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/07/2024 inter alia to consider and approve 1) To consider and approve the Directors Report and Secretarial Audit Report along with annexure for the F.Y. 2023-24; 2) To approve appointment of M/s. Rahul Doshi & Co Chartered Accountants as Internal Auditor of the Company for the Financial Year 2024-25; 3) To approve appointment of Mr. Chintan K. Patel Practicing Company Secretary as a Secretarial Auditor of the Company for F.Y. 2023-24; 4) To take noting of Resignation of Girish Bhatt as Non-Executive Director; 5) To revise and increase the limit of Borrowing power pursuant to Section 180 (1) (c ) of the Companies Act 2013; 6) To Convene the 42nd AGM of the Members of the Company and approve the draft notice of 42nd Annual General Meeting (AGM) of the Company; 7) To consider and fix the Book Closure date for the purpose of 42nd AGM of the Company; 8) To appoint Mr. Chintan K. Patel Practicing Company Secretary (Mem No: A31987 COP: 11959) as Scrutinizer to ascertain voting process of 42nd AGM; Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e., Friday, 5th day of July, 2024 has discussed agendas as described in Outcome. (As per BSE Announcement Dated on 05/07/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.